Celltrion
068270.KS
#658
Rank
NZ$50.40 B
Marketcap
$243.37
Share price
3.23%
Change (1 day)
30.88%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$3.66 B

According to Celltrion 's latest financial reports the company's total liabilities are NZ$3.66 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$2.02 B1.4%
2021-12-31NZ$1.99 B-2.24%
2020-12-31NZ$2.03 B61.12%
2019-12-31NZ$1.26 B4.38%
2018-12-31NZ$1.21 B3.84%
2017-12-31NZ$1.16 B18.41%
2016-12-31NZ$0.98 B-15.6%
2015-12-31NZ$1.16 B2.95%
2014-12-31NZ$1.13 B10.18%
2013-12-31NZ$1.02 B28.32%
2012-12-31NZ$0.80 B42.96%
2011-12-31NZ$0.56 B29.4%
2010-12-31NZ$0.43 B31.58%
2009-12-31NZ$0.32 B-15.51%
2008-12-31NZ$0.39 B700.75%
2007-12-31NZ$48.71 M